InSiteOne is the industry's largest independent provider of integrated services for storage and archiving management of DICOM medical images. As of June, its secure repository incorporated over 324 million images for some 300 client hospitals, imaging centers, and private practices.
InSiteOne is the industry's largest independent provider of integrated services for storage and archiving management of DICOM medical images. As of June, its secure repository incorporated over 324 million images for some 300 client hospitals, imaging centers, and private practices.
The InDex Breast Imaging Archive offers on a pay-per-exam basis the combination of onsite/offsite storage and archiving services or offsite-only archival storage and retrieval for the life of the patient. The fee includes unlimited exam access and retrieval. The archive provides digitally verified image quality and lossless compression, support of electronic workflow, communication tools including prefetching, and optional secure InDex Web distribution and viewing.
The service is targeted to imaging facilities that annually produce 5000 or more mammograms and related (breast MR, breast ultrasound, stereotactic biopsy) images. Services are flexibly tailored to individual customer requirements, but they typically include onsite RAID storage that provides ultrafast local access to 12 to 15 months of images. Studies are archived at InSiteOne's two mirrored data centers in Wallingford, CT, and Phoenix. An ultrasecure Internet VPN is used for archival and retrieval.
InSiteOne also offers a storage repository service to clients with analog screen-film mammography equipment who are digitizing film mammograms for computer-aided detection analysis. A patient database of digitized mammograms can be acquired for future use once digital mammography is implemented. At that time, the stored images can be migrated to internal client storage or retained within the InDex archives.
InSiteOne has a formal comarketing agreement with Hologic. It sells the InDex Breast Imaging Archive through its regional sales staff, select radiology distributors, PACS partners, affiliated hospital group purchasing organizations, and the General Service Administration. Installation is performed by a qualified regional distributor, and service is performed through remote monitoring, with a guaranteed four-hour onsite service response.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.